Despite Henry Schein’s recent underperformance, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from the 14 analysts covering it ...

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and ...

The most recent guidance for Henry Schein (HSIC) was reported on May 5, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $4.80 to $4.94, compared to ...

With its stock down 8.4% over the past month, it is easy to disregard Henry Schein (NASDAQ:HSIC). It seems that the market might have completely ignored the positive aspects of the company's ...

Shares of Henry Schein Inc. HSIC shed 1.60% to $65.17 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 ...

Shares of Henry Schein Inc. HSIC rose 1.13% to $66.23 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.03% to 5,484. ...

An investment fund wants Henry Schein Inc., Long Island’s largest public company by revenue, to shake up its board of directors, reduce expenses and increase profits, according to a source ...

Henry Schein’s HSIC dental software business ... We expect market sentiment to continue to remain positive about the stock. The verification of insurance eligibility has traditionally been ...